Indefinite Delivery Contract 36C25225D0040

Award Date 4/1/25
Last Date to Order 3/31/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
The U.S. Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. The IDC, with a ceiling value of $1,500,000, has a performance period of April 27, 2023 to April 26, 2028. Under this IDC, the VA has issued several firm-fixed-price delivery orders to Jubilant Radiopharma for the...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the provision of radiopharmaceuticals. The IDC, valued at up to $2.6 million, has an ultimate completion date of March 4, 2029 and is not set-aside. As a subsidiary of Jubilant Life Sciences Limited, Jubilant Radiopharma specializes in manufacturing,...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The $950,000 single-award IDC covers the provision of nuclear radiopharmaceuticals to support medical operations for the VA's Veterans Integrated Service Network (VISN) 21. Under this IDC, Jubilant Radiopharma has received multiple firm fixed-price delivery orders to...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Loma Linda Healthcare System to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a small disadvantaged business. The $2,412,781.67 single-award IDC covers the supply of a wide range of radiopharmaceutical products and services, including F-18 FDG, I-123, I-131, Tc-99m, and various other medical isotopes used in diagnostic imaging and cancer treatment procedures....
The Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the procurement of nuclear medicine radiopharmaceuticals. The single-award IDC has a total contract ceiling of $220,000 and a performance period running through March 31, 2030. Jubilant Radiopharma, a for-profit small disadvantaged business, will provide a range of specialized...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit organization, to provide radiopharmaceuticals and related products and services to support diagnostic imaging and treatment procedures at VA medical facilities. The IDC has a potential value of $3,000,000 and runs through September 30, 2028. Jubilant Radiopharma, which is...
The U.S. Department of Veterans Affairs (VA) awarded Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, an Indefinite Delivery Contract (IDC) valued at up to $39.8 million to provide radiopharmaceuticals to VA medical facilities. Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business, will supply diagnostic imaging agents, therapeutic radiopharmaceuticals, and nuclear medicine supplies, including products such as Ga-68...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a small disadvantaged business. The $576,677.75 single-award IDC, with a performance period through September 2029, will provide the VA with a range of radiopharmaceutical products and services to support nuclear medicine operations at the VA Greater Los Angeles Healthcare...
The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, is for the supply of radiopharmaceuticals. The $740,177.94 firm-fixed-price delivery order contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health...
  • 36C25225D0040
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The contract has a ceiling value of $220,000.00 and a period of performance through March 31, 2030.

Under this IDC, Jubilant Radiopharma will provide radiopharmaceuticals and nuclear medicine products to support diagnostic and treatment capabilities for veterans at VA medical facilities across various Veterans Integrated Service Networks (VISNs). The contract is not set aside and is part of Jubilant Radiopharma's portfolio of Indefinite Delivery Vehicles (IDVs) with the VA, including Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) valued up to $39.8 million. These IDVs enable the VA to efficiently procure specialized radiopharmaceuticals and related services as needed to support the agency's nuclear medicine and diagnostic imaging services for veterans.

Generated 4/8/25, 9:51 AM